Status:
UNKNOWN
Decrease of Post-operative Complications by SCVO2 Monitoring an Optimisation of Cardiac Flow
Lead Sponsor:
Assistance Publique Hopitaux De Marseille
Conditions:
Cardiac Flow
Eligibility:
All Genders
50+ years
Phase:
NA
Brief Summary
In operating theater, one of the bigger purpose of anesthetist-resuscitator is to optimize vascular filling (VF) because of a failure or an excess of filling is deleterious for the patient. Several st...
Eligibility Criteria
Inclusion
- \>50 years old
- ASA score ≥ 2
- requiring a major intra-abdominal scheduled surgery
- lasting more than 90 min
- in the visceral surgery, vascular surgery, urological surgery and gynecological surgery sectors
Exclusion
- \<18 years old
- Pregnant or brest feeding patients
- no consentement
- Unstable acute pathology at the time of surgery (acute heart, respiratory or renal failure, severe sepsis or septic shock, hemorrhagic shock);
- rhythm disorders type ACFA early intervention;
- Palliative surgery, ASA 5;
- Patient under guardianship or curatorship.
Key Trial Info
Start Date :
March 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 31 2020
Estimated Enrollment :
220 Patients enrolled
Trial Details
Trial ID
NCT03828565
Start Date
March 1 2019
End Date
October 31 2020
Last Update
February 4 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Laurent Zieleskiewicz
Marseille, PACA, France, 13354